Medicare Part D payments for brand and generic drugs prescribed by dermatologists - 16/08/18
Doi : 10.1016/j.jaad.2018.02.041
Helen B. Powell, BS a, b, Adewole S. Adamson, MD, MPP c, d, ⁎ 
a School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
b Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
c Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
d Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
∗Reprint requests: Adewole S. Adamson, MD, MPP, University of North Carolina Department of Dermatology, Genome Science Building, 250 Bell Tower Dr, Campus Box 7287, Chapel Hill, NC 27599University of North Carolina Department of DermatologyCampus Box 7287Genome Science Building250 Bell Tower DrChapel HillNC27599
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
© 2018
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 79 - N° 3
P. 575-577 - septembre 2018 Retour au numéro
Article précédent
- Vitamin D deficiency in patients with chronic and acute urticaria: A systematic review and meta-analysis
- Tsung-Yu Tsai, Yu-Chen Huang
- Poor interrater reliability of hidradenitis suppurativa phenotypes
- Kelsey R. van Straalen, Tim Verhagen, Barbara Horváth, Christine Ardon, Allard R.J.V. Vossen, Rieke Driessen, Jurr Boer, Angelique L.V. Rondags, Errol P. Prens, Hessel H. van der Zee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?